Future medicine:

What is the most effective and cost-effective strategy to address the epidemic of intestinal disease:

Lifestyle prevention or precision medicine?

At least 80% of all cancers can be prevented by a healthy lifestyle.

We face a dramatically increasing trend in chronic digestive disease cases worldwide. Approximately 40% of all cancer deaths are due to colorectal cancer. By 2040, the number of deaths from colorectal cancer will increase by another 40% in Germany alone.

As of today, personalized medicine cannot yet efficiently answer which drug works best for a given patient: of the currently 10 most financially successful new drug therapies, up to 25 patients need to be treated for one of them to experience a marginal improvement. The lack of treatment success is accompanied by side effects that further reduce the quality of life for the patient and at the same time cause massive additional costs for the entire system and the patient.


It is time for a paradigm shift in healthcare: we need much more focus on prevention measures instead of just more drug-based and “personalized” treatment.


Otherwise, we will never be able to address the root causes of this epidemic in our society and thus will not counteract the rising incidence and its costs.

The best prevention strategies are inexpensive, side-effect free & highly effective.

We need a more holistic, interdisciplinary approach for the prevention and treatment of chronic and digestive diseases, as the latest evidence proves already.

How can digital health and artificial intelligence link prevention measures and personalized medicine to support us in the fight against chronic digestive diseases?

Intriguing and promising facts about the future of medicine.


Request Dr. Schwitalla

as speaker

Request as a consultant